 |
 |
|
Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
15 August 1995 | Volume 123 Issue 4 | Pages 260-268
Objective: To estimate the clinical and economic effects of available invasive and noninvasive management strategies for peptic ulcer and Helicobacter pylori in persons with symptoms suggesting peptic ulcer disease.
Design: Cost-effectiveness analysis using a decision analytic model.
Intervention: 2 immediate endoscopy and 3 noninvasive diagnostic and treatment strategies were evaluated: 1) immediate endoscopy for peptic ulcer and biopsy for H. pylori; 2) immediate endoscopy without biopsy; 3) serologic test for H. pylori; 4) empiric treatment with antisecretory therapy; and 5) empiric treatment with antisecretory therapy and antibiotic agents to eradicate H. pylori.
Measurements: Cost per ulcer cured and cost per patient treated.
Results: The estimated costs per ulcer cured by strategy were as follows: 1) endoscopy and biopsy for H. pylori, $8045; 2) endoscopy without biopsy, $6984; 3) serologic test for H. pylori, $4541; 4) empiric antisecretory therapy, $4835; and 5) empiric antisecretory and antibiotic therapy, $4155. The predicted costs per patient treated were as follows: 1) endoscopy and biopsy for H. pylori, $1584; 2) endoscopy without biopsy, $1375; 3) serologic test for H. pylori, $894; 4) empiric antisecretory therapy, $952; and 5) empiric antisecretory and antibiotic therapy, $818. The cost-effectiveness advantage of the noninvasive strategies diminished as the cost of endoscopy decreased or as the probability of recurrent symptoms increased in patients initially managed without endoscopy.
Conclusion: Endoscopy, although costly, precisely guided diagnosis and treatment and thus potentially reduced the number of patients inappropriately treated. However, the safety and effectiveness of less expensive, less invasive diagnostic and treatment strategies strongly support initial noninvasive care of symptomatic persons thought to have peptic ulcer disease.
Author and Article Information
From the University of Michigan School of Medicine and School of Public Health, Ann Arbor, Michigan, and the University of Pennsylvania, Philadelphia, Pennsylvania.
ARTICLE
Alternative Management Strategies for Patients with Suspected Peptic Ulcer Disease
Requests for Reprints: A. Mark Fendrick, MD, Division of General Medicine, University of Michigan Medical Center, 3116 Taubman Center, Ann Arbor, MI 48109.
This article has been cited by other articles:
|
|
 |
|
  A T Lassen, J Hallas, and O B Schaffalitzky de Muckadell Helicobacter pylori test and eradicate versus prompt endoscopy for management of dyspeptic patients: 6.7 year follow up of a randomised trial Gut, December 1, 2004; 53(12): 1758 - 1763. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. L. A. Arents, J. C. Thijs, A. A. van Zwet, M. Oudkerk Pool, J.-M. Gotz, G. T. van de Werf, K. Reenders, W. J. Sluiter, and J. H. Kleibeuker Approach to Treatment of Dyspepsia in Primary Care: A Randomized Trial Comparing "Test-and-Treat" With Prompt Endoscopy Arch Intern Med, July 14, 2003; 163(13): 1606 - 1612. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. Allison, L. B. Hurley, R. A. Hiatt, T. R. Levin, L. M. Ackerson, and T. A. Lieu A Randomized Controlled Trial of Test-and-Treat Strategy for Helicobacter pylori: Clinical Outcomes and Health Care Costs in a Managed Care Population Receiving Long-term Acid Suppression Therapy for Physician-Diagnosed Peptic Ulcer Disease Arch Intern Med, May 26, 2003; 163(10): 1165 - 1171. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Manes, A. Menchise, C. de Nucci, and A. Balzano Empirical prescribing for dyspepsia: randomised controlled trial of test and treat versus omeprazole treatment BMJ, May 22, 2003; 326(7399): 1118. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N L A Arents, J C Thijs, and J H Kleibeuker A rational approach to uninvestigated dyspepsia in primary care: review of the literature Postgrad. Med. J., December 1, 2002; 78(926): 707 - 716. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N J Talley Dyspepsia: management guidelines for the millennium Gut, May 1, 2002; 50(90004): iv72 - 78. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. L. Peterson, A. M. Fendrick, D. R. Cave, D. A. Peura, S. M. Garabedian-Ruffalo, and L. Laine Helicobacter pylori-Related Disease: Guidelines for Testing and Treatment Arch Intern Med, May 8, 2000; 160(9): 1285 - 1291. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. S. Friedman Helicobacter pylori and Nonulcer Dyspepsia N. Engl. J. Med., December 24, 1998; 339(26): 1928 - 1930. [Full Text]
|
|
|
|
|
|
R. S. Fisher and H. P. Parkman Management of Nonulcer Dyspepsia N. Engl. J. Med., November 5, 1998; 339(19): 1376 - 1381. [Full Text] [PDF]
|
|
|
|
|
|
A. Sonnenberg, J. S. Schwartz, A. F. Cutler, N. Vakil, B. S. Bloom, and for the Gastrointestinal Utilization Trial Study G Cost Savings in Duodenal Ulcer Therapy Through Helicobacter pylori Eradication Compared With Conventional Therapies: Results of a Randomized, Double-blind, Multicenter Trial Arch Intern Med, April 27, 1998; 158(8): 852 - 860. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. MICHETTI Vaccine against Helicobacter pylori: fact or fiction? Gut, December 1, 1997; 41(6): 728 - 730. [Full Text] [PDF]
|
|
|
|
|
|
T. C K Tham and D. R Lichtenstein Comparison groups were not clear in study BMJ, September 7, 1996; 313(7057): 623 - 623. [Full Text]
|
|
|
|
 |
|
 Strategies for Patients with Suspected Peptic Ulcer Journal Watch Dermatology, September 1, 1995; 1995(901): 16 - 16. [Full Text]
|
|
|
|
 |
|
 STRATEGIES FOR PATIENTS WITH SUSPECTED PEPTIC ULCER Journal Watch (General), August 18, 1995; 1995(818): 3 - 3. [Full Text]
|
|
Article
